medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2022, Number 4

<< Back Next >>

Rev Latin Infect Pediatr 2022; 35 (4)

Mycobacterium tuberculosis as a cause of lymphadenitis in a clinically immunocompetent pediatric patient

Urueña PY, Vargas ÁJE, Fuentes SE, Martínez PR

Language: Spanish
References: 10
Page: 157-161
PDF size: 283.88 Kb.


ABSTRACT

Introduction: tuberculosis is one of the main public health problems worldwide, and the child population is no exception. Although the main manifestations are due to pneumonic pathology, it is not uncommon for extrapulmonary clinical data to occur. The ganglionic chains are one of the main sites of involvement in this variable of infection, and its presentation is associated with some type of immunodeficiency. Case report: 8-year-old male, previously healthy, who came to this hospital unit reporting difficult-to-control fever associated with the appearance of enlarged lymph nodes in the left side of the body. Surgery of the affected conglomerates was performed and through the pathological analysis of the biopsy, the presence of Mycobacterium tuberculosis was reported, for which the diagnosis of extrapulmonary tuberculosis of lymphatic origin was integrated. It was subsequently protocolized and the corresponding treatment was provided, evolving adequately to date. Conclusion: in the presence of enlarged lymph nodes in pediatric patients, it is important to always consider the possibility that they are undergoing an infectious process associated with Mycobacterium tuberculosis. A thorough clinical evaluation and an adequate study protocol are important in this type of scenario to achieve timely diagnosis and immediate treatment of this disease.


REFERENCES

  1. OMS. Informe mundial sobre la tuberculosis 2020: sinopsis. Ginebra: Organización Mundial de la Salud; 2021.

  2. Mandal N, Anand PK, Gautam S, Das S, Hussain T. Diagnosis and treatment of paediatric tuberculosis: An insight review. Crit Rev Microbiol. 2017; 43 (4): 466-480.

  3. Centro Nacional de Programas Preventivos y Control de Enfermedades. Casos nuevos de Tuberculosis Todas Formas Estados Unidos Mexicanos 1990-2016 [internet]. Ciudad de México: CENAPRECE [citado noviembre 20, 2021]. Disponible en: http://www.cenaprece.salud.gob.mx/programas/interior/micobacteriosis/descargas/pdf/8CasosTbTodas16.pdf

  4. Rodriguez-Takeuchi SY, Renjifo ME, Medina FJ. Extrapulmonary tuberculosis: pathophysiology and imaging findings. Radiographics. 2019; 39 (7): 2023-2037.

  5. Martínez de Cuellar C, Lovera D, Gatti L, Ojeda L, Apodaca S, Zarate CC et al. Tuberculosis: factores de riesgo asociados a mortalidad en pacientes ≤ 19 años hospitalizados en el Instituto de Medicina Tropical. Pediatr. 2019; 46 (2): 77-81.

  6. Sabillón Vásquez DL, Jovel López LE. Formas clínicas y perfil epidemiológico de tuberculosis en niños, Hospital Nacional Dr. Mario Catarino Rivas. Acta Pediátrica Hondureña. 2015; 4 (2): 298-306.

  7. Martínez L, Vázquez S, Flores MM, Notejane M, Zabala C, Giachetto G et al. Tuberculosis extra-pulmonar en niños bajo 15 años de edad internados en el Centro Hospitalario Pereira Rossell, Uruguay. Rev Chil Infectol. 2020; 37 (5): 577-583.

  8. Neyro SE, Squassi IR, Medín M, Caratozzolo A, Martínez BA, Cerqueiro MC. Tuberculosis ganglionar periférica en pediatría: 16 años de experiencia en un centro pediátrico de tercer nivel de Buenos Aires, Argentina. Arch Argent Pediatr. 2018; 116 (6): 430-436.

  9. Tovar Díaz M, Tang Velásquez AM, Concha Mendoza ND. Tuberculosis extrapulmonar en pediatría: un reto diagnóstico. Medicas UIS. 2013; 26 (1): 45-58.

  10. NORMA Oficial Mexicana NOM-006-SSA2-2008, Para el control y la prevención de la tuberculosis. México: DOF; 2013.




2020     |     www.medigraphic.com